News

POP QUIZ: Latest NACI updates on COVID-19 vaccines
Based on recent updates from, all of the following statements about COVID-19 vaccination are true, EXCEPT for . . .
EnsembleIQ's Brandlab, named 'digital team of the year,' expands to fulfill B2B demand for comprehensive creative agency
EnsembleIQ—the company that runs The Medical Post and Pharmacy Practice + business and other B2B media brands—is expanding into the B2B creative agency space.

Canadian drugmaker says its COVID-19 vaccine is effective

Medicago announced Tuesday that its two-dose vaccine was 71% effective at preventing COVID-19 infection in a large, late-stage study that included several variants including the delta variant.
New projections: Ontario could see 3,000 cases, 400 in ICU in Jan even without variant

The COVID-19 Science Advisory Table says public health measures and increased vaccination are needed to reduce virus transmission as cases rise in most public health units.
Better ob-gyn by design: Doc goes viral after asking Twitterverse how to improve his clinic

Twitter users chimed in with suggestions ranging from where to put the scale to how to angle the exam table (hint: with the patients' private parts facing away from the door).
An exciting find: Sildenafil a potential drug candidate to prevent Alzheimer’s disease

Studies by American researchers suggest that the erectile dysfunction drug sildenafil could decrease a person’s risk for Alzheimer’s disease.
HIV, Hepatitis C and syphilis tests coming to pharmacies in Alta., NS and NL

Pharmacies in Newfoundland and Labrador, Alberta, and Nova Scotia will offer rapid tests for HIV, Hepatitis C and syphilis by next fall.
Omicron vs. delta: A look at the key questions

It's too soon to know how likely it is that omicron will spread more efficiently than delta, or, if it does, how fast it might take over.
6 solutions from Canadian doctors to the physician shortage

Canada continues to have a physician shortage. Here Canadian doctors outline ways to improve the access challenges in this country.
Canada to manufacture Merck COVID-19 antivirals if regulator approves

The drug company has invested $19 million to scale up production of its antiviral drug, molnupiravir, at Thermo Fisher Scientific's facility in Whitby, Ont.